NASDAQ:RWLKRewalk Robotics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rewalk Robotics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.42 -0.02 (-4.04 %) (As of 04/3/2020 04:00 PM ET) Add Compare Share Today's Range$0.42Now: $0.42▼$0.4650-Day Range$0.43MA: $0.66▼$0.8852-Week Range$0.41Now: $0.42▼$10.08Volume73,700 shsAverage Volume366,562 shsMarket Capitalization$5.36 millionP/E RatioN/ADividend YieldN/ABeta2.12 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingRewalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.50, Rewalk Robotics has a potential upside of 733.3% from its current price of $0.42.Amount of Analyst CoverageRewalk Robotics has only been the subject of 1 research reports in the past 90 days. Previous Next 3.1 Community Rank Outperform VotesRewalk Robotics has received 395 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRewalk Robotics has received 252 “underperform” votes. (Add your “underperform” vote.)Community SentimentRewalk Robotics has received 61.05% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Rewalk Robotics and other stocks. Vote “Outperform” if you believe RWLK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRewalk Robotics does not currently pay a dividend.Dividend GrowthRewalk Robotics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rewalk Robotics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Rewalk Robotics is held by insiders.Percentage Held by InstitutionsOnly 5.37% of the stock of Rewalk Robotics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Rewalk Robotics are expected to decrease by -100.00% in the coming year, from ($1.04) to $0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rewalk Robotics is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rewalk Robotics is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRewalk Robotics has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.45 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RWLK Previous Symbol CUSIPN/A CIK1607962 Webhttp://www.rewalk.com/ Phone972-4959-0123Debt Debt-to-Equity Ratio0.14 Current Ratio2.07 Quick Ratio1.77Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.87 million Price / Sales1.10 Cash FlowN/A Price / Cash FlowN/A Book Value$1.48 per share Price / Book0.28Profitability EPS (Most Recent Fiscal Year)($2.70) Net Income$-15,550,000.00 Net Margins-319.13% Return on Equity-140.68% Return on Assets-61.10%Miscellaneous Employees58 Outstanding Shares12,754,000Market Cap$5.36 million Next Earnings Date5/5/2020 (Estimated) OptionableNot Optionable Receive RWLK News and Ratings via Email Sign-up to receive the latest news and ratings for RWLK and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:RWLK Rates by TradingView Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions How has Rewalk Robotics' stock been impacted by COVID-19 (Coronavirus)? Rewalk Robotics' stock was trading at $0.6050 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RWLK shares have decreased by 30.6% and is now trading at $0.42. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Rewalk Robotics? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Rewalk Robotics. When is Rewalk Robotics' next earnings date? Rewalk Robotics is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Rewalk Robotics. How were Rewalk Robotics' earnings last quarter? Rewalk Robotics Ltd (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, February, 20th. The medical device company reported ($0.49) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.36) by $0.13. The medical device company had revenue of $1.18 million for the quarter, compared to the consensus estimate of $2.35 million. Rewalk Robotics had a negative return on equity of 140.68% and a negative net margin of 319.13%. View Rewalk Robotics' earnings history. What price target have analysts set for RWLK? 1 brokerages have issued 1 year price targets for Rewalk Robotics' stock. Their forecasts range from $3.50 to $3.50. On average, they anticipate Rewalk Robotics' stock price to reach $3.50 in the next year. This suggests a possible upside of 733.3% from the stock's current price. View analysts' price targets for Rewalk Robotics. Has Rewalk Robotics been receiving favorable news coverage? Media stories about RWLK stock have been trending very negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Rewalk Robotics earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutRewalk Robotics. Who are some of Rewalk Robotics' key competitors? Some companies that are related to Rewalk Robotics include NanoVibronix (NAOV), Bionik Laboratories (BNKL), Precision Therapeutics (POAI), Ocugen (OCGN) and Avitar (AVTI). What other stocks do shareholders of Rewalk Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Two Harbors Investment (TWO), Novocure (NVCR), Blackrock Capital Investment (BKCC), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP). Who are Rewalk Robotics' key executives? Rewalk Robotics' management team includes the following people: Mr. Lawrence J. Jasinski, CEO & Director (Age 62)Mr. Ori Gon, Chief Financial Officer (Age 38)Ms. Miri Pariente, VP of QA & Operations (Age 42)Mr. Loren Wass, VP of Sales & ReimbursementMr. Andy Dolan, VP of Marketing What is Rewalk Robotics' stock symbol? Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK." How do I buy shares of Rewalk Robotics? Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Rewalk Robotics' stock price today? One share of RWLK stock can currently be purchased for approximately $0.42. How big of a company is Rewalk Robotics? Rewalk Robotics has a market capitalization of $5.36 million and generates $4.87 million in revenue each year. The medical device company earns $-15,550,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe. View additional information about Rewalk Robotics. What is Rewalk Robotics' official website? The official website for Rewalk Robotics is http://www.rewalk.com/. How can I contact Rewalk Robotics? Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected] This page was last updated on 4/3/2020 by MarketBeat.com StaffFeatured Article: How to start trading in the forex market?
